drugset / Trial / NCT05124925
Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.
NaSingle-groupOpen-labelTreatment
Summary
This study aims at elucidating the mechanism of action of ianalumab in salivary glands and explore relationships with clinical assessments
Timeline
- Start
- 2022-07-27
- Primary completion
- 2024-06-26
- Completion
- 2026-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ianalumab | Monoclonal antibody | 300 mg | Subcutaneous |